Jefferies Group’s Editas Medicine EDIT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.08M | Buy |
170,142
+91,552
| +116% | +$1.12M | 0.02% | 331 |
|
|
2022
Q2 | $930K | Buy |
78,590
+14,932
| +23% | +$177K | 0.01% | 462 |
|
|
2022
Q1 | $1.21M | Buy |
63,658
+30,691
| +93% | +$584K | 0.01% | 483 |
|
|
2021
Q4 | $875K | Buy |
32,967
+20,338
| +161% | +$540K | 0.01% | 592 |
|
|
2021
Q3 | $519K | Buy |
12,629
+10,237
| +428% | +$421K | ﹤0.01% | 726 |
|
|
2021
Q2 | $135K | Sell |
2,392
-9,615
| -80% | -$545K | ﹤0.01% | 943 |
|
|
2021
Q1 | $504K | Buy |
+12,007
| New | +$504K | ﹤0.01% | 704 |
|
|
2020
Q1 | – | Sell |
-28,100
| Closed | -$832K | – | 1258 |
|
|
2019
Q4 | $832K | Buy |
+28,100
| New | +$832K | 0.01% | 843 |
|